FeesSafety
Pluang+

Pomerantz LLP investigates Portillo’s for possible securities fraud after revenue and sales targets cut.

Market News
01 Jul 2026, 00:16 WIB
GlobeNewsWire
View Source
Bearish
Pomerantz LLP investigates Portillo’s for possible securities fraud after revenue and sales targets cut.

Pomerantz LLP is investigating Portillo’s Inc. for potential securities fraud following the company's lowered revenue growth and adjusted EBITDA targets in 2025. Portillo’s also reduced its same-restaurant sales and unit growth outlook, which led to a 5.67% drop in its stock price on September 10, 2025. The investigation aims to determine if Portillo’s officers or directors engaged in unlawful business practices, with investors encouraged to join a class action lawsuit. This could impact investor confidence and future legal proceedings.

More News

Gatekeeper now available on AWS Marketplace for streamlined vendor and contract management.

Gatekeeper now available on AWS Marketplace for streamlined vendor and contract management.

Gatekeeper, a unified Vendor and Contract Lifecycle Management solution, is now available for purchase through AWS Marketplace. This integration allows organizations using AWS to buy Gatekeeper via their existing AWS accounts, simplifying vendor gove...

Others
Bullish
1 hour ago
Organic Grower Summit 2026 adds live ag tech demos at Reservoir Farms for hands-on grower experience

Organic Grower Summit 2026 adds live ag tech demos at Reservoir Farms for hands-on grower experience

The Organic Grower Summit (OGS) 2026, held Dec. 2–3 in Monterey, California, introduces an exclusive offsite AGTech Reception & Field Demos at Reservoir Farms. Sponsored by John Deere, Western Growers Association, and Reservoir, this event offers gro...

Others
Bullish
2 hours ago
New brain cancer drug data and trials spotlighted at Society for Neuro-Oncology meeting

New brain cancer drug data and trials spotlighted at Society for Neuro-Oncology meeting

At the 31st Annual Society for Neuro-Oncology meeting, biotech firms NeOnc, Nuvation Bio, Jazz Pharmaceuticals, and Cerenome presented new clinical data on brain cancer treatments. Highlights include NeOnc's NEO100 and NEO212 therapies advancing towa...

Market News
Bullish
2 hours ago
Subsea 7 wins $50M-$150M contract for deepwater project in US Gulf of Mexico starting 2028

Subsea 7 wins $50M-$150M contract for deepwater project in US Gulf of Mexico starting 2028

Subsea 7 has secured a sizeable contract from Kosmos Energy for the Tiberius Project in the US Gulf of Mexico, involving fabrication and installation of subsea infrastructure at about 2,200 meters depth. The work includes a 14-kilometer steel riser, ...

Market News
Bullish
2 hours ago
GlobeNewswire issues daily market update with no new financial news on Nov 13, 2026

GlobeNewswire issues daily market update with no new financial news on Nov 13, 2026

GlobeNewswire released its End of Day Message for November 13, 2026, confirming its role as an FCA-approved primary information provider. The update mainly reiterates its operational status and disclaimers, without reporting any new financial events ...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App